title: INFORM; C-TONG 0805: A multicenter, double blind randomized phase III trial of maintenance gefitinib compared to placebo in advanced non-small cell lung cancer.
authors: Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill, North Carolina, USA.
authors: Thomas E
authors: TE
authors: Stinchcombe